For example, anti-inflammatory compounds, such as ibuprofen, aspirin and indomethacin, which are known inhibitors of NFκB [66–69] could be explored in combination with pro-apoptotic agents, or rhTNFα, or other ligands of TNFR1 for glioblastoma treatment. This evidence concerns the gene NFKB1 and glioblastoma.